Historic Merger of Kean University and New Jersey City University AdvancesThe Middle States Commission on Higher Education has advanced the merger between Kean University and New Jersey City University.UNION, N.J., April 27, 2026 (GLOBE NEWSWIRE) — The Middle States Commission on Higher Education (MSCHE) has advanced the merger between Kean University and New Jersey City University (NJCU), marking a historic milestone that will reshape public higher education in New Jersey. The merger will serve as a model for institutions nationwide pursuing partnerships that advance sustainability and expand student opportunities.
The merger will officially close on July 1, 2026, when Kean acquires control of NJCU. At that time, all NJCU employees will become new Kean employees. Following completion of the U.S. Department of Education’s...
$2 million upfront with up to approximately $4 million of potential aggregate proceeds upon the exercise in full of warrants
DETROIT, April 27, 2026 (GLOBE NEWSWIRE) — Amesite Inc. (Nasdaq: AMST), developer of the AI‑native NurseMagic™ platform and EMR for non‑acute care, today announced that it has entered into definitive agreements for the purchase and sale of 696,866 shares of its common stock, at a purchase price of $1.435 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, the Company has agreed to issue to the investor unregistered Series A-1 warrants to purchase up to 696,866 shares of common stock and unregistered Series A-2 warrants to purchase up to 696,866 shares of common stock. The warrants will have an exercise price of $1.435 per share and will be exercisable beginning...
LOWELL, Mass., April 27, 2026 (GLOBE NEWSWIRE) — MACOM Technology Solutions Inc. (“MACOM”), a leading supplier of semiconductor products, today announced that it will enter into Long-Term Supply Agreements (“LTSAs”) with IQE plc (“IQE”) for epitaxial services spanning multiple technologies. The LTSAs are expected to further secure supply in support of MACOM’s growth strategy.
In parallel with the LTSAs, subject to customary closing conditions, including obtaining certain regulatory clearances, MACOM will participate in a financing transaction with IQE. MACOM’s proposed investment in IQE will total £45 million, in the form of equity and a convertible loan note. As part of the investment, MACOM will receive representation on IQE’s board of directors.
“IQE is an important supplier to MACOM. We believe this transaction will strengthen...
PRESS RELEASE
AB SCIENCE announces a final agreement on the renegotiation of the repayment terms of its loans with all of its financial creditorsAB Science has reached a final agreement with its financial creditors
This agreement provides for a two-year deferral of repayment of the State-Guaranteed Loans and a 12-month deferral of the repayment date of the EIB Covid credit
The savings over the period will be invested in R&DParis, April 27, 2026, 6pm CET
AB Science SA (Euronext – FR0010557264 – AB) announces today that a final agreement has been reached with its financial creditors for the 24-month deferral of repayment of its bank debt (for a total amount of approximately €3.7 million) and the 12-month deferral of repayment of a loan subscribed with the EIB (for a total principal amount of €12 million, initially repayable...
WARREN, N.J., April 27, 2026 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced continued progress within its artificial intelligence initiative, Tevogen.AI, including the near completion of its PredicTcell™ training algorithm and early steps toward commercial readiness.
PredicTcell™, Tevogen.AI’s proprietary machine learning model designed to identify immunologically active peptides, is approaching the final stages of its training phase. The model has been trained on one of the industry’s largest curated peptide datasets, with feature expansion now exceeding 180 parameters, contributing to an approximate 10% improvement in precision.
As development progresses, the Company has begun evaluating potential co-development partnerships to support broader application of the...
PRESS RELEASE
Arcueil, April 27th, 2026
Declaration of transactions on own shares conducted from April 20 to April 24, 2026
Within the framework of the authorizations granted by the General Assembly on February 3, 2026, to operate on its shares and in accordance with the regulations related to share buybacks, Aramis Group hereby declares the following purchases of own shares (FR0014003U94) made from April 20 to April 24, 2026 (excluding the liquidity contract):Name of the issuer
Issuer identifier code
Transaction date
Financial instrument identifier code
Total daily volume (in number of shares)
Daily weighted average purchase price of shares
MarketAramis Group
9695002Q984W0T41WB42
2026-04-20
FR0014003U94
4,936
4.0501
XPARAramis Group
9695002Q984W0T41WB42
2026-04-21
FR0014003U94
4,753
4.0409
XPARAramis Group
9695002Q984W0T41WB42
2026-04-22
FR0014003U94
7,550
3.9733
XPARAramis...
PRESS RELEASE
Courbevoie, France – April 27, 2026
Availability of preparatory documents for Bureau Veritas’ Combined Shareholders’ Meeting of May 19, 2026
Bureau Veritas’ Combined Shareholders’ Meeting will be held on Tuesday May 19, 2026, at 3:00 p.m., at the Company’s registered office located at Tour Alto (in the Auditorium on the 5th floor), 4 Place des Saisons, Courbevoie (92400), France, for the purpose of deliberating on the agenda and the draft resolutions set out in the preliminary Notice of Meeting (Avis de réunion) published on April 3, 2026 in the legal gazette Bulletin des Annonces Légales et Obligatoires no. 40.
The main instructions for participating and voting at the Meeting are described in the above-mentioned preliminary Notice of Meeting (Avis de réunion) and in the convening Notice of Meeting (Avis de convocation)...
ABU DHABI, United Arab Emirates, April 27, 2026 (GLOBE NEWSWIRE) — Ittihad International Investment LLC (“Ittihad” or “the Group”), a leading diversified industrial conglomerate in the UAE, today announced its financial results for the full year ended December 31, 2025.
Financial and Operational Highlights – FY 2025 vs FY 2024The Group recorded USD 3.5 billion in revenue, up 4.3% year-on-year, and USD 179 million in adjusted EBITDA¹, up 22.0% year-on-year — representing growth on top of 6.0% growth in the prior year — with the adjusted EBITDA² margin expanding from 12.4% to 13.5%.
All three principal operating segments delivered year-on-year EBITDA growth, reflecting the breadth and resilience of the Group’s diversified portfolio:Consumer Goods Manufacturing (CGM): EBITDA grew 3.5% year-on-year,...
Sports.com Predict to launch ahead of the 2026 FIFA World Cup, positioning SEGG Media to capitalize on the world’s largest sporting event through transaction-based fan engagement.
Platform is designed as a long-term growth engine, targeting high-margin revenue opportunities within the rapidly expanding global sports predictions market.FORT WORTH, Texas, April 27, 2026 (GLOBE NEWSWIRE) — Sports.com Predict, the new sports predictions platform unveiled last week by Sports Entertainment Gaming Global Corporation (NASDAQ: SEGG, LTRYW) (the “Company” or “SEGG Media”), is expected to be live in advance of the 2026 FIFA World Cup.
With global attention turning to the world’s biggest sporting tournament, Sports.com Predict will offer fans a new way to engage with football’s biggest moments through predictions. Developed as a scalable...
Before you continue, please confirm the following:
Professional advisers only
I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.
Important Notice for Investors:
The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.
No Investment Advice:
The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.
High Risks:
Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.
Sole Responsibility:
The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.
No Guarantees:
Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.
Regional Restrictions:
The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.
Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.
